BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gottifredi V. Targeting DNA damage response kinases in cancer therapy. Mutat Res 2020;821:111725. [PMID: 33157476 DOI: 10.1016/j.mrfmmm.2020.111725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Lin J, Huang S, Li M, Yu W, Zhao Y, Guo J, Zhang P, Huang X, Qiao Y. Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR-Mediated Base Editors. Adv Sci (Weinh) 2022;:e2200717. [PMID: 36045417 DOI: 10.1002/advs.202200717] [Reference Citation Analysis]
2 Chen J, Jia X, Li Z, Song W, Jin C, Zhou M, Xie H, Zheng S, Song P. Targeting WEE1 by adavosertib inhibits the malignant phenotypes of hepatocellular carcinoma. Biochem Pharmacol 2021;188:114494. [PMID: 33684390 DOI: 10.1016/j.bcp.2021.114494] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]